A

Active Director Director DIN 10812440
DIN 10812440 First appointment Oct 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Akshay

Data last updated:

Akshay is a Director at Radious Hospital Private Limited (since 2024). The company operates in Healthcare. Radious Hospital Private Limited reported revenue of ₹75.4 Lakh (FY 2025).

DIN 10812440
Primary Designation Director
Industry Healthcare
First Appointment 18 Oct 2024
Oldest Company Age 2 yrs
Largest company Radious Hospital Private Limited · ₹75.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Radious Hospital Private Limited U86100DL2024PTC425352
Director18 Oct 20242024₹75.4 Lakh (FY 2025)Active

Board colleagues of Akshay

Directorship timeline

Open interactive timeline →
Radious Hospital Private Limited
Premium access

Shareholding and investment profile for Akshay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay

Akshay currently holds 1 directorship: Radious Hospital Private Limited (Director, since 18 Oct 2024, revenue ₹75.4 Lakh (FY 2025)).

Akshay was first appointed on 18 Oct 2024 as Director at Radious Hospital Private Limited.

The current boards of Akshay's companies include Abhishek Chaudhary (Radious Hospital Private Limited), Arun Aggarwal (Radious Hospital Private Limited), Nikhil Chhikara (Radious Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available